Aortic regurgitation
A condition where the aortic valve in the heart does not close tightly
Aortic regurgitation (AR), also known as aortic insufficiency, is a condition in which the aortic valve in the heart does not close tightly, allowing some of the blood that was pumped out of the heart's left ventricle to leak back into it. This can lead to a variety of symptoms and complications if left untreated.
Pathophysiology
Aortic regurgitation occurs when the aortic valve leaflets fail to close completely during diastole, the phase of the heart cycle when the heart relaxes and fills with blood. This incompetence of the valve allows blood to flow backward from the aorta into the left ventricle. Over time, this can lead to volume overload of the left ventricle, causing it to dilate and eventually leading to heart failure.

Causes
Aortic regurgitation can be caused by a variety of conditions, including:
- Rheumatic fever
- Infective endocarditis
- Aortic dissection
- Marfan syndrome
- Bicuspid aortic valve
- Hypertension
- Degenerative changes in the aortic valve

Symptoms
Patients with aortic regurgitation may experience a range of symptoms, including:
- Dyspnea (shortness of breath)
- Fatigue
- Palpitations
- Angina (chest pain)
- Syncope (fainting)
Diagnosis
The diagnosis of aortic regurgitation is typically made using a combination of physical examination, echocardiography, and other imaging techniques. A characteristic finding on auscultation is a diastolic murmur heard best along the left sternal border.

Treatment
Treatment for aortic regurgitation depends on the severity of the condition and the presence of symptoms. Options include:
- Medical management with vasodilators and diuretics
- Surgical intervention, such as aortic valve replacement
Prognosis
The prognosis for patients with aortic regurgitation varies depending on the severity of the condition and the timeliness of treatment. Early intervention can improve outcomes significantly.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian